Research | michrxconsulting.com

February 18, 20190Comments

Two Crises In One: As Drug Use Rises, So Does Syphilis

By Anna Gorman February 14, 2019 Drug syringe and cooked heroin on spoon Public health officials grappling with record-high syphilis rates around the nation have pinpointed what appears to be a major

July 27, 20170Comments

IAS 2017:Antiretroviral Therapy – ART: Season Two

On Tuesday July 25th one of the oral poster presentations at IAS 2017 was Antiretroviral Therapy - ART: Season Two Five presentations were presented: 1. Darunavir/Cobicistat/Entricitabine/TAF The First Once Daily STR

July 25, 20170Comments

IAS 2017: HIV and the Liver: Co-Infection and Complications

Some more information from IAS 2017 in Paris, France. This video is of the oral abstract presentation on HIV and the Liver: Co-Infection and Complications which consists of 5 abstract presentations

July 24, 20170Comments

IAS 2017 Oral Poster Presentation: Antivirals and Pregnancy

One of the Oral poster presentations on day 1 at IAS 2017 in Paris France was poster presentations on: Antivirals & Pregnancy You can watch the presentation here: #IAS2017 #AntiviralsAndPregnancy #OralPoster

March 24, 20170Comments

First HIV Drug Approved By FDA Turns 30

This past week, March 19th to be exact was the 30th anniversary of the day when FDA approved AZT (Zidovudine) brand name Retrovir, the first drug to treat HIV/AIDS. This was

July 21, 20150Comments

Study Sheds Light on How Tenofovir is Processed in Different Body Tissues

Written by Liz Highleyman; HIVandhepatitis.com Tenofovir, which is widely used for HIV treatment and prevention, is activated in a tissue-specific manner, being processed by different enzymes in immune cells, the vagina,

February 26, 20150Comments

HIV Maturation Inhibitor BMS-955176 Looks Promising In Early Study

A second-generation HIV maturation inhibitor, BMS-955176, demonstrated good safety and high potency, including activity against viral strains that were not susceptible to an earlier drug in this class, researchers reported

February 4, 20150Comments

Caring for HIV Patients In Your Pharmacy- On the Cusp Of Success

Finally the world is coming up to speed and is finally realizing what we’ve known for a long time ….the simple fact that Pharmacists are Healthcare Providers. The shift in

January 30, 20150Comments

PREZCOBIX Approved By FDA

Today the FDA approved Janssen Therapeutics combination HIV antiretroviral, PREZCOBIX which is a combination of darunavir 800mg and cobicistat 150mg. PREZCOBIX is indicated for the treatment of HIV-1 in combination with

January 29, 20150Comments

EVOTAZ Approved By FDA

Today the FDA approved Bristol-Myers Squibb Company’s new HIV antiretroviral combination EVOTAZ. Evotaz is a combination of atazanavir and Cobicistat and is approved for the treatment of HIV-1 infection in

by Michelle

« Older Articles